Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
| MINT-CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-03 | 2019-11-29 | 71041 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
| MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
| MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71066 |
| MINT-LOSARTAN | 25.0MG | TABLET | Actual shortage | 2019-01-03 | 2020-01-27 | 71069 |
| MINT-LOSARTAN | 50.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71074 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-03 | 2019-02-07 | 71078 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-02-04 | 2020-01-27 | 74450 |
| MINT-METFORMIN | 500MG | TABLET | Actual shortage | 2019-02-04 | 2019-02-05 | 74455 |
| MINT-HYDRALAZINE | 10MG | TABLET | Resolved | 2019-02-28 | 2019-09-03 | 77148 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80792 |
| MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
| MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
| MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |